Studies quality of life and stress in stroke patients and their caregivers
Observes quality of life and stress in adults with stroke and their caregivers.
Plain-language title generated from the registry record
Registry title: Cerebrovascular Disease: Quality of Life (CODE: QoL)
Key facts
- Where
- Zurich, SwitzerlandSee the site
Where in Switzerland
- Department of Neurology, University Hospital ZurichZurich, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Zurich
- Trial code
- NCT06443268
- Record updated
- 5 June 2024
- Original description
The goal of this observational study is to learn about quality of life, stress and caregiver burden in patients with stroke and their caregivers.Read full original descriptionShow less
Cerebrovascular Disease: Quality of Life (CODE: QoL)
The goal of this observational study is to learn about quality of life, stress and caregiver burden in patients with stroke and their caregivers.
The main question is:
• to discover the factors associated with quality of life and stress in patient-caregiver dyads.
Participants will be asked to fill out questionnaires and agree to provide a hair sample (in order to measure stress hormones in hair) and consent to use of their routine clinical and laboratory data.
Researchers will compare a group of participants without stroke to establish a comparable baseline.
Inclusion: over 18 years old; No previous stroke OR previous stroke >3 years ago; No significant disability (maximum mRS 1); ambulatory patients at the University Hospital of Zurich (USZ), Dept. of Neurology; Patients' AND caregiver's ability to give informed consent; Patients' AND close relative's / caregiver's willingness to participate; over 18 years old; Patients diagnosed with either transient ischemic attack, ischemic stroke or intracerebral hemorrhage and their caregivers; Caregiver of a patient as described above, age over 18 years; Hospitalized or ambulatory patients at the University Hospital of Zurich (USZ) included within 28 days from event; Patients' AND caregiver's ability to give informed consent; Patients' AND caregiver's willingness to participate.
Exclusion: Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months; Main Group:; Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months.
Control group:.